Table 2. Screening/Treatment Capacities by Setting
Intervention Basic Limited Enhanced Maximal
Patholog y If there is a
way to send
patholog y for
review when
needed, that
should occur.
Patholog y
services in
development
H&E usually
available, IHC
and molecular
tests are usually
not available.
Patholog y
services usually
available and
IHC and
molecular tests
may be available.
Patholog y
available with
specialist
patholog y
templates,
genetic/
molecular testing
available.
Palliative care Palliative
care service is
not available.
Limited
medications
for pain may be
available.
Pain and
symptom
management
available;
palliative care
service is in
development
Palliative care
specialty service
not always
available.
Specialist
palliative care
service available.
Table 3. Screening: Asymptomatic, Average-Risk Population,
High-Incidence Areas, Age 50 –75
Method
Basic Limited Enhanced Maximal Rec Number
gFOBT People should
receive highly
sensitive gFOBT
every 1 (preferred)
– 2 years if
resources are
available (based
on resources and
patient adherence).
People should receive highly sensitive gFOBT
annually.
1.1
(Strong
Recommendation;
H)
FIT People may receive
FIT, if available,
every 1 (preferred)
– 2 years (based
on resources and
patient adherence).
People may receive FIT annually.
OR 1.2
(Moderate
Recommendation;
I)
(cont'd)
Treatment
